FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2802034622> ?p ?o ?g. }

• W2802034622 endingPage "1682" @default.
• W2802034622 startingPage "1671" @default.
• W2802034622 abstract "We evaluated progression-free survival (PFS) rate of patients treated with lenalidomide/dexamethasone (Len/Dex), the efficacy of the combination, and the prognostic significance of treatment at biochemical vs. clinical relapse on PFS in 207 consecutive myeloma patients treated with Len/Dex in second line, according to routine clinical practice in Greece. First-line treatment included bortezomib-based (63.3%) or immunomodulatory drug-based (34.8%) therapies; 25% of patients underwent autologous stem cell transplantation. Overall response rate was 73.4% (17.8% complete response and 23.7% very good partial response); median time to best response was 6.7 months. Overall, median PFS and 12-month PFS rate was 19.2 months and 67.6%, respectively. 67.5% of patients had biochemical relapse and 32.5% had clinical relapse prior to initiation of Len/Dex. Median PFS was 24 months for patients treated at biochemical relapse vs. 13.2 months for those treated at clinical relapse (HR:0.63, p = 0.006) and the difference remained significant after adjustment for other prognostic factors. Type of relapse was the strongest prognostic factor for PFS in multivariate analysis. These real-world data confirm the efficacy of Len/Dex combination at first relapse; more importantly, it is demonstrated for the first time outside a clinical trial setting that starting therapy with Len/Dex at biochemical, rather than at clinical relapse, is a significant prognostic factor for PFS, inducing a 37% reduction of the probability of disease progression or death." @default.
• W2802034622 created "2018-05-17" @default.
• W2802034622 creator A5004716597 @default.
• W2802034622 creator A5007546071 @default.
• W2802034622 creator A5010017616 @default.
• W2802034622 creator A5016543067 @default.
• W2802034622 creator A5018345688 @default.
• W2802034622 creator A5018736661 @default.
• W2802034622 creator A5019265156 @default.
• W2802034622 creator A5022988911 @default.
• W2802034622 creator A5024960041 @default.
• W2802034622 creator A5027287182 @default.
• W2802034622 creator A5028089840 @default.
• W2802034622 creator A5040422302 @default.
• W2802034622 creator A5041125510 @default.
• W2802034622 creator A5041407463 @default.
• W2802034622 creator A5049817881 @default.
• W2802034622 creator A5050709644 @default.
• W2802034622 creator A5050806596 @default.
• W2802034622 creator A5052241210 @default.
• W2802034622 creator A5052434492 @default.
• W2802034622 creator A5052918575 @default.
• W2802034622 creator A5064642096 @default.
• W2802034622 creator A5065368922 @default.
• W2802034622 creator A5071607681 @default.
• W2802034622 creator A5078247349 @default.
• W2802034622 creator A5081856546 @default.
• W2802034622 creator A5083275335 @default.
• W2802034622 creator A5087794120 @default.
• W2802034622 creator A5090511737 @default.
• W2802034622 date "2018-05-13" @default.
• W2802034622 modified "2023-10-02" @default.
• W2802034622 title "Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival" @default.
• W2802034622 cites W1897859400 @default.
• W2802034622 cites W1978377409 @default.
• W2802034622 cites W1985864219 @default.
• W2802034622 cites W1991473434 @default.
• W2802034622 cites W1992538067 @default.
• W2802034622 cites W2003734726 @default.
• W2802034622 cites W2014737912 @default.
• W2802034622 cites W2021954218 @default.
• W2802034622 cites W2041469831 @default.
• W2802034622 cites W2044436186 @default.
• W2802034622 cites W2044636425 @default.
• W2802034622 cites W2125721471 @default.
• W2802034622 cites W2128084036 @default.
• W2802034622 cites W2141105112 @default.
• W2802034622 cites W2144728882 @default.
• W2802034622 cites W2144930991 @default.
• W2802034622 cites W2146193272 @default.
• W2802034622 cites W2150570212 @default.
• W2802034622 cites W2160545597 @default.
• W2802034622 cites W2169336006 @default.
• W2802034622 cites W2201190784 @default.
• W2802034622 cites W2216303864 @default.
• W2802034622 cites W2290703702 @default.
• W2802034622 cites W2343386476 @default.
• W2802034622 cites W2469453488 @default.
• W2802034622 cites W2486629951 @default.
• W2802034622 cites W2528329272 @default.
• W2802034622 cites W2596288557 @default.
• W2802034622 cites W2979893644 @default.
• W2802034622 cites W3187491162 @default.
• W2802034622 cites W4252175385 @default.
• W2802034622 doi "https://doi.org/10.1007/s00277-018-3361-2" @default.
• W2802034622 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6828143" @default.
• W2802034622 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29943159" @default.
• W2802034622 hasPublicationYear "2018" @default.
• W2802034622 type Work @default.
• W2802034622 sameAs 2802034622 @default.
• W2802034622 citedByCount "15" @default.
• W2802034622 countsByYear W28020346222018 @default.
• W2802034622 countsByYear W28020346222019 @default.
• W2802034622 countsByYear W28020346222020 @default.
• W2802034622 countsByYear W28020346222021 @default.
• W2802034622 countsByYear W28020346222022 @default.
• W2802034622 countsByYear W28020346222023 @default.
• W2802034622 crossrefType "journal-article" @default.
• W2802034622 hasAuthorship W2802034622A5004716597 @default.
• W2802034622 hasAuthorship W2802034622A5007546071 @default.
• W2802034622 hasAuthorship W2802034622A5010017616 @default.
• W2802034622 hasAuthorship W2802034622A5016543067 @default.
• W2802034622 hasAuthorship W2802034622A5018345688 @default.
• W2802034622 hasAuthorship W2802034622A5018736661 @default.
• W2802034622 hasAuthorship W2802034622A5019265156 @default.
• W2802034622 hasAuthorship W2802034622A5022988911 @default.
• W2802034622 hasAuthorship W2802034622A5024960041 @default.
• W2802034622 hasAuthorship W2802034622A5027287182 @default.
• W2802034622 hasAuthorship W2802034622A5028089840 @default.
• W2802034622 hasAuthorship W2802034622A5040422302 @default.
• W2802034622 hasAuthorship W2802034622A5041125510 @default.
• W2802034622 hasAuthorship W2802034622A5041407463 @default.
• W2802034622 hasAuthorship W2802034622A5049817881 @default.
• W2802034622 hasAuthorship W2802034622A5050709644 @default.
• W2802034622 hasAuthorship W2802034622A5050806596 @default.
• W2802034622 hasAuthorship W2802034622A5052241210 @default.
• W2802034622 hasAuthorship W2802034622A5052434492 @default.
• W2802034622 hasAuthorship W2802034622A5052918575 @default.

• next